Last reviewed · How we verify

Tauvid — Competitive Intelligence Brief

Tauvid (FLORTAUCIPIR F 18) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neuroscience.

marketed Microtubule-associated protein tau Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Tauvid (FLORTAUCIPIR F 18) — Avid Radiopharms Inc. Tauvid binds to tau protein in the brain, allowing for visualization of tau pathology through PET imaging.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tauvid TARGET FLORTAUCIPIR F 18 Avid Radiopharms Inc marketed Microtubule-associated protein tau 2020-01-01
Methylthioninium Methylthioninium Shandong Cancer Hospital and Institute phase 3 Microtubule-associated protein tau, Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tauvid — Competitive Intelligence Brief. https://druglandscape.com/ci/flortaucipir-f-18. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: